| Literature DB >> 30834643 |
Colwyn A Headley1,2, Abigail Gerberick3, Sumiran Mehta3, Qian Wu1, Lianbo Yu4, Paolo Fadda4,5, Mahmood Khan6, Latha Prabha Ganesan7, Joanne Turner1,2, Murugesan V S Rajaram1.
Abstract
Biological aging dynamically alters normal immune and cardiac function, favoring the production of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and increased instances of cardiac distress. Cardiac failure is the primary reason for hospitalization of the elderly (65+ years). The elderly are also increasingly susceptible to developing chronic bacterial infections due to aging associated immune abnormalities. Since bacterial infections compound the rates of cardiac failure in the elderly, and this phenomenon is not entirely understood, the interplay between the immune system and cardiovascular function in the elderly is of great interest. Using Mycobacterium avium, an opportunistic pathogen, we investigated the effect of mycobacteria on cardiac function in aged mice. Young (2-3 months) and old (18-20 months) C57BL/6 mice were intranasally infected with M. avium strain 104, and we compared the bacterial burden, immune status, cardiac electrical activity, pathology, and function of infected mice against uninfected age-matched controls. Herein, we show that biological aging may predispose old mice infected with M. avium to mycobacterial dissemination into the heart tissue and this leads to cardiac dysfunction. M. avium infected old mice had significant dysrhythmia, cardiac hypertrophy, increased recruitment of CD45+ leukocytes, cardiac fibrosis, and increased expression of inflammatory genes in isolated heart tissue. This is the first study to report the effect of mycobacteria on cardiac function in an aged model. Our findings are critical to understanding how nontuberculous mycobacterium (NTM) and other mycobacterial infections contribute to cardiac dysfunction in the elderly population.Entities:
Keywords: Arrhythmia; ECG; Mycobacterium avium; aging; fibrosis; nontuberculous mycobacterium
Mesh:
Substances:
Year: 2019 PMID: 30834643 PMCID: PMC6516181 DOI: 10.1111/acel.12926
Source DB: PubMed Journal: Aging Cell ISSN: 1474-9718 Impact factor: 11.005
Figure 1Mycobacterium avium bacterial burden in lungs of young and old mice. C57BLC57BL/66 mice intranasally infected with M. avium strain 104 (1.2 × 105 CFU) were euthanized at 10, 20, and 30 days postinfection, and lungs were homogenized in sterile saline buffer. Serial lung (a), spleen (b), and liver (c) tissue dilutions were plated onto OADC supplemented 7H11 plates and incubated for 21 days at 37°C. CFU were counted and expressed as Log10 CFU; 4–5 mice per group per time point (mean ± SEM; *p < 0.05). The images shown in (d) are hearts of M. avium infected young and old mice, stained with anti‐Mycobacterium tuberculosis polyclonal antibody followed by anti‐rabbit Alexa flour 568 conjugated secondary antibody. The section was examined for M. avium by confocal microscopy. Images shown are representative of hearts from five young and old animals. (e) Randomly selected confocal images (5 images per heart, n = 5) from M. avium infected young and old mice hearts were analyzed by ImageJ, and the mean fluorescent intensities were plotted in the graph (mean ± SEM; *p < 0.05)
Figure 2Mycobacterium avium infection causes cardiac arrhythmia in old mice. Surface electrocardiogram (ECG) recordings of control and M. avium (200 CFUs) infected young and old mice at baseline and at 30 days postinfection by PowerLab 4/30 (AD Instruments). ECG traces were analyzed using LabChart 8 Pro (AD Instruments). (a) Shown are representative ECG data from sham‐treated young mice (N = 5), (b) M. avium infected young mice (N = 5), (c) sham‐treated old mice, and (d) M. avium infected old mice at day 30 postinfection. Data shown are a representative of 5 mice (N = 5)
Figure 3Hearts of Mycobacterium avium infected old mice undergo cardiac hypertrophy. To assess heart function in vivo, 2D‐echocardiography (Vevo 2100, Visualsonics) was performed in M. avium (200 CFUs) infected young and old mice at 30 days postinfection. Representative baseline M‐mode echocardiographs from M. avium infected young (a) and old (b) mice (N = 6). (c) Atleast two M‐mode echocardiogram measurements from each mouse were used to determine the LVIDd, left ventricular end‐diastolic dimension; LVIDs, left ventricular end‐systolic dimension, ejection fraction (EF%), fractional shortening (FS%), IVSTd, interventricular septal thickness in diastole; IVSTs, interventricular septal thickness in systole; LVPWd, posterior wall thickness in diastole; LVPWDs, posterior wall thickness in systole, a p < 0.05; b p < 0.005; c p < 0.0005. (d) Graph shows the heart weight over the body weight of young and old mice (baseline), 20 mice/group (mean ± SEM; *p < 0.05)
Figure 4NTM infection induces cardiac fibrosis in old mice. Heart sections from sham and Mycobacterium avium infected young and old mice were stained with Masson's trichrome to identify fibrosis in cardiac tissue. Image shown here are representative of whole heart and interstitial fibrosis from sham‐treated young (a) and old (c) mice that were infected with M. avium (b and d). The image shown in right panel is 40× magnification and representative of five animals/group. The trichrome staining (blue color) in the heart sections was isolated using Photoshop CC in color range selection mode. The total intensity of the stained area in the heart sections was further quantified via ImageJ using color intensity to multiply area with staining. Graph shown in (e) young mice sham‐treated and M. avium infected, (f) old mice sham‐treated M. avium infected, and (g) comparison of M. avium infected young and old mice. Data shown in graphs are cumulative data from five animals (mean ± SEM; ** p < 0.005; ***p < 0.0005; N = 5)
Figure 5Changes of immune‐related gene expression in the hearts of Mycobacterium avium infected young and old mice. Hearts were collected from sham‐treated or M. avium infected (30 days postinfection) young and old mice to isolate mRNA. The mRNA samples were analyzed using NanoString assay on the mouse pan‐cancer immune panel, followed by data analysis in nSolver software. The heat map showing genes whose induction in heart tissue by M. avium infection was more than 1.5‐fold different in young and old mice (a), p < 0.05. The vein diagrams shown in (b‐e) is the number of genes that were upregulated, downregulated, or no change in expression in young and old mice that were infected or uninfected with M. avium. Two‐tailed Student's t test is used to select differentially expressed genes with values p < 0.05
Figure 6Comparative analysis of chemokine and chemokine receptors, inflammatory genes, and validation of NanoString data. (a) Heat map showing differential gene expression of chemokines and chemokine receptors in the heart tissue of uninfected and M. avium infected young and old mice. (b) Selected inflammatory gene expression of uninfected and M. avium infected young and old mice. (c) Validation of IL‐1β and TNF–α by qRT–PCR. The total RNA from heart tissue was reverse transcribed and used to determine the expression of IL‐1β and TNF–α by qRT–PCR using Taqman primers (N = 5). Data shown in graphs are cumulative data from five animals (mean ± SEM; **p < 0.005)
Top significantly enriched canonical pathways in Mycobacterium avium infected old animal hearts by IPA
| Pathway | −log ( | Ratio | Molecules |
|---|---|---|---|
| Granulocyte Adhesion and Diapedesis | 32 | 0.188 | Ccl2,CXCL12,ITGAM,IL1RL1,Ccl8,CSF3R,ITGB2,CCL3L3,THY1,Cxcl11,ITGA1,IL1RN,C5AR1,TNF,CXCL16,CCL4,ICAM2,Ccl7,IL1B,CCL5,TNFRSF1B,CXCL10,FPR2,CCL24,CCL21,CDH5,CCL19,IL18,Ccl9,IL1A,JAM3,PECAM1 |
| Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 28.1 | 0.119 | IL1RL1,CXCL12,ATF2,FCGR1A,TLR1,SOCS3,TLR9,IL16,MAPKAPK2,FOS,TLR8,C5AR1,TNF,CREBBP,TLR6,TLR2,VEGFC,IRAK1,TLR7,IL1B,CCL5,TNFVEGFA,NFATC1,IL18,MYC,MAP2K4,CCL2,IL1A,MAPK1,SOCS1,FCGR3A/FCGR3B |
| Pattern Recognition Receptors in Recognition of Bacteria and Viruses | 26 | 0.197 | TLR1,TLR9,C3AR1,TLR8,IRF7,C5AR1,TNF,OAS3,TLR6,TLR2,PRKCE,TGFB3,TLR7,IL1B,CCL5,C1QB,OAS2,CASP1,TGFB2,DDX58,IL18,NLRP3,MAP2K4,IL1A,CLEC6A,MAPK1,IFNB1 |
| Toll‐like Receptor Signaling | 23.7 | 0.276 | IL1RL1,IRAK1,SIGIRR,TLR7,IL1B,TLR1,CD14,TLR9,FOS,TLR8,IL18,IL1RN,TNF,MAP2K4,IL1A,TICAM2,MAPK1,TAB1,TLR6,TLR2,ECSIT |
| IL‐10 Signaling | 19.8 | 0.261 | IL1RL1,IL1B,SOCS3,CCR1,CD14,FCGR2A,FOS,CCR5,IL18,IL1RN,FCGR2B,TNF,MAP2K4,IL1A,MAPK1,IL4R,TAB1,IKBKE |
| p38 MAPK Signaling | 19.1 | 0.175 | IL1RL1,IRAK1,TGFB3,ATF2,MAP3K5,IL1B,TNFRSF1B,TGFB2,PLA2G6,FADD,MEF2C,MAPKAPK2,HSPB2,IL18,MYC,IL1RN,TNF,MAP2K4,IL1A,CREBBP,TAB1 |
| IL‐6 Signaling | 18.1 | 0.157 | IL1RL1,IL1B,VEGFA,TNFRSF1B,CD14,TLR9,MAPKAPK2,IL6ST,HSPB2,IL18,PIK3CD,IL1RN,IL1R1,MAP2K4,TNF,MAP2K2,IL1A,SOCS1,MAPK8,HRAS,IKBK |
| NF‐κB Signaling | 18.5 | 0.128 | IRAK1,SIGIRR,PDGFRB,EGFR,TLR7,IL1B,KDR,TLR1,TNFRSF1B,TLR9,FCER1G,,IGF1R,TLR8,IL18,IL1RN,TNF,LCK,IL1A,CREBBP,TAB1,TLR6,TNFRSF11A,TLR2 |
| Atherosclerosis Signaling | 17.3 | 0.157 | CXCL12,IL1B,COL3A1,ITGB2,MSR1,COL1A1,PLA2G6,CMA1,LYZ,IL18,CD36,IL1RN,TNF,CLU,CCL2,IL1A,SELPLG,CSF1,TNFRSF12A,CCR3 |
| Fibrosis/Hepatic Stellate Cell Activation | 24.8 | 0.155 | CCR7,IL1RL1,COL1A1,SMAD4,A2M,CCR5,FN1,TNF,SMAD3,VEGFC,TGFB3,PDGFRB,COL4A1,EGFR,IL1B,CCL5,KDR,TNFRSF1B,CD14,VEGFA,COL3A1,TGFB2,CCL21,IGF1R,CCL2,BCL2,IL1A,CSF1,IL4R |
| Activation of IRF by Cytosolic Pattern Recognition Receptors | 13 | 0.206 | ATF2,STAT2,DDX58,IFIT2,IRF7,MAP2K4,TNF,ISG15,CREBBP,IFNB1,IKBKE |
| IL‐12 Signaling and Production in Macrophages | 11.4 | 0.11 | PRKCE,TGFB3,TGFB2,TLR9,MAF,PPARG,IL23R,FOS,LYZ,IL18,TNF,CLU,MAP2K4,MAPK1,TLR2,IKBKE |
| TGF‐β Signaling | 8.38 | 0.118 | FOS,TGFB3,IRF7,MAP2K4,BCL2,SMAD3,TGFB2,MAPK1,CREBBP,TAB1,SMAD4 |
| HMGB1 Signaling | 7.52 | 0.0863 | FOS,TGFB3,IL18,IL1B,TNFRSF1B,TNF,MAP2K4,CCL2,IL1A,TGFB2,MAPK1,TLR9 |
| Death Receptor Signaling | 7.27 | 0.108 | HSPB2,TNFRSF10A,MAP3K5,TNFRSF1B,TNF,MAP2K4,BCL2,FADD,BID,IKBKE |
| Chemokine Signaling | 6.91 | 0.117 | FOS,CCR5,CXCL12,CCL5,CCL2,CCL24,MAPK1,CCL4,CCR3 |
| Apoptosis Signaling | 6.08 | 0.0938 | PRKCE,MAP3K5,TNFRSF1B,TNF,MAP2K4,BCL2,MAPK1,BID,IKBKE |
| Cardiac Hypertrophy Signaling | 4.97 | 0.0498 | IGF1R,TGFB3,ATF2,MAP3K5,MAP2K4,TGFB2,MAPK1,TLR9,CREBBP,TAB1,MEF2C,MAPKAPK2 |
| IL‐17A Signaling in Fibroblasts | 4.5 | 0.143 | FOS,CCL2,MAPK1,LCN2,IKBKE |
Top cardiac toxicity molecules by IPA
| Ingenuity Toxicity Lists | −log ( | Ratio | Molecules |
|---|---|---|---|
| Cardiac Necrosis/Cell Death | 13 | 0.0782 | IRAK1,TXNIP,MAP3K5,IL1B,SOCS3,VEGFA,CASP1,FADD,LCN2,MAPKAPK2,IL6ST,DPP4,IL1RN,THBD,TNF,MAP2K4,BCL2,RRAD,MAPK1,ANGPT1,SPP1,CYBB,TLR2 |
| TGF‐β Signaling | 8.23 | 0.115 | FOS,TGFB3,IRF7,MAP2K4,BCL2,SMAD3,TGFB2,MAPK1,CREBBP,TAB1,SMAD4 |
| Cardiac Fibrosis | 7.99 | 0.0698 | MAP3K5,IL1B,VEGFA,EGR1,IL16,IGF1R,FN1,TNF,NLRP3,SMAD3,ETS1,SPP1,CYBB,TLR2,IKBKE |
| Cardiac Hypertrophy | 7.37 | 0.0511 | Ccl2,IL1RL1,CXCL12,HCK,EGFR,MAP3K5,IL1B,SMAD4,MEF2C,IL6ST,IL18,FN1,TNF,MAP2K4,RRAD,MAPK1,TAB1,NT5E |
| Increases Cardiac Dysfunction | 3.51 | 0.0893 | Ccl2,CD36,MAP3K5,TNF,CYBB |
| Increases Cardiac Dysfunction | 2.87 | 0.0357 | CCR2,CYBB |
| Increases Damage of Mitochondria | 2.24 | 0.182 | IL1B,TNF |
| Increases Cardiac Proliferation | 1.8 | 0.06 | EGFR,TNF,ITGB2 |
| Increases Heart Failure | 1.55 | 0.08 | TNF,CASP1 |
| Increases Cardiac Dilation | 1.17 | 0.05 | MAP3K5,TNF |
| TGF‐β Signaling | 1.05 | 0.0104 | FOS |
| Cardiac Fibrosis | 0.723 | 0.00465 | CYBB |
| Cardiac Necrosis/Cell Death | 0.603 | 0.0034 | CYBB |